Modification of ventriculo–arterial coupling by spironolactone in nonischemic dilated cardiomyopathy

AIMS: We sought to clarify the role of ventriculo–arterial (V–A) coupling in the treatment of nonischemic dilated cardiomyopathy (NIDCM) by adding a mineralocorticoid receptor antagonist (MRA) to conventional anti‐failure therapy. METHODS AND RESULTS: We employed cardiac magnetic resonance imaging t...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:ESC Heart Fail
Prif Awduron: Lawson, Mark A., Hansen, David E., Gupta, Deepak K., Bell, Susan P., Adkisson, Douglas W., Mallugari, Ravinder R., Sawyer, Douglas B., Ooi, Henry, Kronenberg, Marvin W.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2021
Pynciau:
Original Research Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8006677/
https://ncbi.nlm.nih.gov/pubmed/33403831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13161
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg